---
figid: PMC9327107__ltab005_fig1
figtitle: 'Immuno-antibiotics: targeting microbial metabolic pathways sensed by unconventional
  T cells'
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- Bacillus subtilis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Listeria monocytogenes
- Salmonella enterica
- Klebsiella pneumoniae
- Vibrio cholerae
- Lactococcus lactis
- Mycolicibacterium smegmatis
- Acinetobacter baumannii
- Enterobacter cloacae
- Klebsiella aerogenes
- Listeria innocua
- Enterobacter cloacae MR2
- Homo sapiens
- Macaca mulatta
- Plasmodium falciparum
- Toxoplasma gondii
- Mus musculus
- Saccharomyces cerevisiae
- Vicugna pacos
organisms_ner:
- Klebsiella aerogenes
- Acinetobacter baumannii
- Vibrio cholerae
- Mycolicibacterium smegmatis
- Listeria innocua
- Escherichia coli str. K-12 substr. MG1655
pmcid: PMC9327107
filename: ltab005_fig1.jpg
figlink: /pmc/articles/PMC9327107/figure/F1/
number: F1
caption: 'Reaction steps of the MEP pathway of isoprenoid biosynthesis and generation
  of the Vγ9/Vδ2 T cell activator HMB-PP. Red colour denotes the individual enzymes
  involved in the pathway; green arrows depict the targets of the Dxr inhibitors fosmidomycin
  and FR-900098, and the IspH inhibitors 2,4-dioxo-4-phenylbutanoate (C23.07) and
  4-(2,5-dimethylphenyl)-4-oxobutanoate (C23.28). Enzymes: Dxs, 1-deoxy-d-xylulose
  5-phosphate (DOXP) synthase; Dxr, DOXP reductoisomerase; IspD, 2-C-methyl-d-erythritol
  4-phosphate (MEP) cytidylyltransferase; IspE, 4-diphosphocytidyl-2-C-methyl-d-erythritol
  kinase; IspF, 2-C-methyl-d-erythritol 2,4-cyclodiphosphate (MEcPP) synthase; IspG,
  (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP) synthase (GcpE); IspH,
  HMB-PP reductase (LytB).'
papertitle: 'Immuno-antibiotics: targeting microbial metabolic pathways sensed by
  unconventional T cells.'
reftext: Matthias Eberl, et al. Immunother Adv. 2021 Jan;1(1):ltab005.
year: '2021'
doi: 10.1093/immadv/ltab005
journal_title: Immunotherapy Advances
journal_nlm_ta: Immunother Adv
publisher_name: Oxford University Press
keywords: γδ T cells | MAIT cells | microbial infection | antibiotics | immunotherapy
automl_pathway: 0.8973773
figid_alias: PMC9327107__F1
figtype: Figure
redirect_from: /figures/PMC9327107__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9327107__ltab005_fig1.html
  '@type': Dataset
  description: 'Reaction steps of the MEP pathway of isoprenoid biosynthesis and generation
    of the Vγ9/Vδ2 T cell activator HMB-PP. Red colour denotes the individual enzymes
    involved in the pathway; green arrows depict the targets of the Dxr inhibitors
    fosmidomycin and FR-900098, and the IspH inhibitors 2,4-dioxo-4-phenylbutanoate
    (C23.07) and 4-(2,5-dimethylphenyl)-4-oxobutanoate (C23.28). Enzymes: Dxs, 1-deoxy-d-xylulose
    5-phosphate (DOXP) synthase; Dxr, DOXP reductoisomerase; IspD, 2-C-methyl-d-erythritol
    4-phosphate (MEP) cytidylyltransferase; IspE, 4-diphosphocytidyl-2-C-methyl-d-erythritol
    kinase; IspF, 2-C-methyl-d-erythritol 2,4-cyclodiphosphate (MEcPP) synthase; IspG,
    (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP) synthase (GcpE); IspH,
    HMB-PP reductase (LytB).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - dxs
  - ispD
  - ispE
  - ispF
  - ispG
  - ispH
  - dxr
---
